CALGARY, Canada, July 8, 2020-- Orpyx (orpyx.com), an innovator in digital health therapeutics to prevent diabetic foot complications, today announced the close of a $7.6M Series A investment round. Paddock Capital Inc. led the investment round with participation from existing and new investors, including Aphelion Capital, Thin Air Labs, InterGen Capital, Relentless Venture Fund, ICM Asset Management, Anges Quebec, Picante Capital Corp. and Viewpoint Group. The investment brings Orpyx's total funding since inception of the company to $18.5M and will help the company expand its North American commercialization efforts as well as broaden and accelerate technology development.
CALGARY, Canada, July 8, 2020 /PRNewswire/ -- Orpyx (orpyx.com), an innovator in digital health therapeutics to prevent diabetic foot complications, today announced the close of a $7.6M Series A investment round. Paddock Capital Inc. led the investment round with participation from...
Huayin Health, a Guangzhou-based medical technology firm, has completed a Series C round financing of RMB600 million (US$85 million) led by GL Capital. Qianhai Fund of Funds, Everest Venture Capital, BOCG Investment, Chongqing Venture Capital and In Capital also participated in the round. Established in 2009, Huayin Health is a comprehensive medical technology group engaged [...] Chinese Medical Technology Firm Huayin Health Secures $85M In Series C Round comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.
In this panel, a general partner and founders discussed their competitive edge in disrupting the traditional insurance industry, the opportunities in the international markets they operate in; and their ambition for building next-generation insurtech companies. Speakers include Ugur Samut, Co-Founder & CEO, Medigo; Sam Hodges, Co-Founder & CEO, Vouch; Igor Mascarenhas, Co-Founder & CEO, Pier; Kai Stinchcombe, Co-Founder & CEO, True Link Financial; and Karthik Reddy, Co-Founder & Managing Partner, Blume Ventures.
The Chinese scientist who created the world's first gene-edited children has been sentenced to three years in prison by a Chinese court. He Jiankui, a biophysicist trained at Rice University and Stanford, shocked the world last year with his claim to have created genetically modified humans, twins referred to as Lulu and Nana.
During this panel, a general partner and founders discussed the areas within the health care industry that are ripe for disruption, how they overcome regulatory hurdles building their health-focused startups, and the next steps in scaling their businesses. Speakers include Dr. John Hamer, Managing Partner, DCVC Bio; Sid Viswanathan, Co-Founder and President, Truepill; Jonas Muff, CEO, Merantix Healthcare; and Hilary Coles, Co-Founder and VP of hims and hers.
Meet Truepill Co-Founder Sid Viswanathan: Telemedicine Will Make Medicine 10x Better, Cheaper, Faster
Garry Tan, venture capitalist and co-founder at Initialized Capital, sat down with Sid Viswanathan, co-founder of Truepill. Truepill is an API for all needs for telemedicine. Telemedicine has the potential to bring down costs and make high quality care more accessible for every person on the planet. This video highlights their west coast HQ and fulfillment center out of which they provide pharmacy services for dozens of telemedicine startups and practices large and small, shipping to all 50 states. Here you'll learn how as a founder, you need to choose a problem space that you could want to work on for 10 years or more.
Signifier Medical Technologies Closes An Oversubscribed Series B Funding Round; Driving Innovation In The Sleep Market
LONDON, June 17, 2019 /PRNewswire/ -- Signifier Medical Technologies, previously known as Snoozeal, an innovator in the sleep disordered breathing market, today announced it has closed an oversubscribed Series B funding, aiming to invest further in R&D and prepare the company for...
MENLO PARK, Calif., Oct. 22, 2018 /PRNewswire/ -- Earlens Corporation, Inc., a privately held medtech company committed to dramatically improving hearing aids, announced today it has completed an $87 million preferred stock financing round led by new investor KCK Ltd., a family investment ...
PLEASANTON, Calif., September 20, 2018-- Providence Medical Technology, Inc., an innovator in tissue-sparing surgical equipment and implants for cervical spine fusion surgery, today announced the closing of $25 million in new equity financing. Revelation Partners led the round with participation from the private equity investment team at BMO Global Asset Management (EMEA), MVM Life Science Partners, Medvest Capital, and Aphelion Capital. Inclusive of this new investment, Providence has raised a total of $53 million in equity financing since its 2008 inception.